A multicentre randomised trial to compare uterine safety of raloxifene witha continuous combined hormone replacement therapy containing oestradiol andnorethisterone acetate |
Participants in the Euralox 1 Study Group are listed on pages 165-166;Neven, P.;Lunde, T.;Benedetti-Panici, P.;Tiitinen, A.;Marinescu, B.;de Villiers, T.;Hillard, T.;Cano, A.;Peer, E.;Quail, D.;Nickelsen, T.; |
BJOG: An International Journal of Obstetrics and Gynaecology |
2003-02-01 |
查看 |